Rockland Technimed Ltd has introduced a new line of breakthrough paradigm shifting and natural Magnetic Resonance Imaging- MRI Contrast Agents namely Oxy-17®. for use in conjunction with an unaltered MRI scanner. Molecular biomarker's  for use in drug development, pre-clinical and clinical use. A result of over 15 years of research and development effort, during this period of time it has demonstrated its usefulness in tracking all facets of oxygen metabolism using normally installed MRI scanners. Examples are:

• Ability to assess tissue viability in cases of neurological and cardiovascular catastrophes such as ( Heart or Stroke attack), or other tissue injury
• Ability to determine Oxygen Extraction Fraction [OEF] of Tissue such as in stroke at a 1 mm resolution , because they can cross the intact blood brain barrier. [presently can only be done with PET/CT, using a radio-active isotope oxygen-15] at its best resolution of 6 mm.
• Current PET studies show, with OEF as an indicator the “Golden hour - 3 Hours after onset of Stroke” can now be extended up to 12 hours or more, enabling the clinician and thereby saving lives, reducing disabilities and costs.
• Ability to track tumor angiogenesis
• Oxy-17® and OxyMaps™ are useful as " Non Invasive Realtime Tissue Stress Monitor" to evaluate normal and abnormal Oxygen Consumption rates in a biological subject, without any limitations on repeating the test due to dosage and/or other limitations.